1 |
receptor for advanced glycation end products
(2809 times)
|
Biochemistry (298 times)
|
HMGB1 (533 times) AGEs (225 times) sRAGE (204 times)
|
1995 The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.
|
2 |
receptor for AGEs
(657 times)
|
Biochemistry (96 times)
|
AGEs (459 times) AGE (135 times) ROS (60 times)
|
1993 Expression of receptors for advanced glycosylation end products on renal cell carcinoma cells in vitro.
|
3 |
AGE receptor
(64 times)
|
Biochemistry (10 times)
|
AGEs (35 times) AGE (23 times) ROS (6 times)
|
1997 Advanced glycation end products, oxidant stress and vascular lesions.
|
4 |
Rating Scale for Aggressive Behaviour in the Elderly
(7 times)
|
Geriatrics (6 times)
|
MMSE (2 times) AD (1 time) BARS (1 time)
|
1997 Aggressive behaviour in the Chinese elderly--validation of the Chinese version of the rating scale for aggressive behaviour in the elderly (RAGE) in hospital and nursing home settings.
|
5 |
AGEs-their receptor
(4 times)
|
Medicine (4 times)
|
AGEs (4 times) ROS (1 time) VEGF (1 time)
|
2005 Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients.
|
6 |
rapid amplification of genomic ends
(3 times)
|
Molecular Biology (2 times)
|
PCR (2 times) gDNA (1 time)
|
1997 Rapid amplification of gene ends (RAGE) from gene libraries by anchored PCR.
|
7 |
recombinase-assisted genome engineering
(3 times)
|
Science (2 times)
|
BAC (1 time) GT (1 time) Mpn (1 time)
|
2013 Implementation of stable and complex biological systems through recombinase-assisted genome engineering.
|
8 |
RNAi-Assisted Genome Evolution
(3 times)
|
Biotechnology (2 times)
|
RNAi (1 time)
|
2014 Genome-wide RNAi screen reveals the E3 SUMO-protein ligase gene SIZ1 as a novel determinant of furfural tolerance in Saccharomyces cerevisiae.
|
9 |
RAGEDeltacyto
(2 times)
|
Cell Biology (1 time)
|
SCs (1 time)
|
2010 Human muscle satellite cells show age-related differential expression of S100B protein and RAGE.
|
10 |
random activation of gene expression
(2 times)
|
Biotechnology (1 time)
|
cDNA (1 time) EST (1 time) HTS (1 time)
|
2001 Creation of genome-wide protein expression libraries using random activation of gene expression.
|
11 |
rapid acquisition gradient-echo
(2 times)
|
Diagnostic Imaging (1 time)
|
IPH (1 time) MP (1 time) MR (1 time)
|
1997 Gadolinium-enhanced breath-hold three-dimensional time-of-flight MR angiography of the abdominal and pelvic vessels: the value of ultrafast MP-RAGE sequences.
|
12 |
rapid gradient-echo
(2 times)
|
Diagnostic Imaging (2 times)
|
MP (1 time) SIR (1 time) TOF (1 time)
|
1993 Three-dimensional MR imaging of the coronary arteries: preliminary clinical experience.
|
13 |
Recent understanding of this process has confirmed that AGE-their receptor
(2 times)
|
Medicine (2 times)
|
AGEs (2 times) TAGE (2 times) AD (1 time)
|
2005 Potential therapeutic implication of nifedipine, a dihydropyridine-based calcium antagonist, in advanced glycation end product (AGE)-related disorders.
|
14 |
redox balance, expression of the AGE receptor
(2 times)
|
Biochemistry (2 times)
|
AGEs (2 times) GLP-1 (1 time)
|
2010 Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T 15.
|
15 |
reducing receptor for AGEs
(2 times)
|
Metabolism (2 times)
|
AGEs (2 times) ROS (2 times) ADMA (1 time)
|
2012 Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.
|
16 |
region of advanced glycosylation end-product specific receptor
(2 times)
|
Heart Failure (1 time)
|
AD (1 time) CI (1 time) HF (1 time)
|
2020 Association of rs2070600 in advanced glycosylation end-product specific receptor with prognosis of heart failure.
|
17 |
renal tumor antigen
(2 times)
|
Neoplasms (2 times)
|
HCC (1 time) MALDI-PSD (1 time) MMP-9 (1 time)
|
1998 Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method.
|
18 |
research advanced glycation end-product receptors
(2 times)
|
Otorhinolaryngologic Diseases (1 time)
|
3'-UTR (1 time) ARE (1 time) SGC (1 time)
|
2004 AU-rich elements in the mRNA 3'-untranslated region of the rat receptor for advanced glycation end products and their relevance to mRNA stability.
|
19 |
restriction analysis of gene expression
(2 times)
|
Pathology (1 time)
|
RT-PCR (1 time)
|
2003 Tyrosine-kinase expression profiles in human gastric cancer cell lines and their modulations with retinoic acids.
|
20 |
role of AGEs and their receptor
(2 times)
|
Cell Biology (2 times)
|
AGEs (2 times) DM (1 time) IL (1 time)
|
2010 Advanced glycation end products, oxidative stress and diabetic nephropathy.
|
21 |
AGE-specific receptor
(1 time)
|
Rheumatology (1 time)
|
AGE (1 time) IgG (1 time) OA (1 time)
|
2004 Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis.
|
22 |
anti-AGE receptor
(1 time)
|
Allergy and Immunology (1 time)
|
AGE-HSA (1 time) AGEs (1 time) ECs (1 time)
|
2007 Advanced glycation end products induce actin rearrangement and subsequent hyperpermeability of endothelial cells.
|
23 |
Currently, advanced glycation end product
(1 time)
|
Neoplasms (1 time)
|
CI (1 time) sRAGE (1 time) WMD (1 time)
|
2014 Circulating soluble advanced glycation end product is inversely associated with the significant risk of developing cancer: evidence from a meta-analysis.
|
24 |
down-regulate the mRNA level of the AGE receptor
(1 time)
|
Biochemistry (1 time)
|
AGEs (1 time) CAT (1 time) EGCG (1 time)
|
2007 Protective effect of (-)-epigallocatechin gallate against advanced glycation endproducts-induced injury in neuronal cells.
|
25 |
radical scavenging; AGE cross-link breaking; AGE receptor
(1 time)
|
Biology (1 time)
|
AGE (1 time) AGEs (1 time)
|
2006 Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes.
|
26 |
RAGE Ab
(1 time)
|
Allergy and Immunology (1 time)
|
at-HMGB1 (1 time) DRG (1 time) ds-HMGB1 (1 time)
|
2014 Identification of a functional interaction of HMGB1 with Receptor for Advanced Glycation End-products in a model of neuropathic pain.
|
27 |
RAGE gene knockout
(1 time)
|
Cardiology (1 time)
|
ALI (1 time) ARDS (1 time) IL (1 time)
|
2017 Role of Receptor for Advanced Glycation End Products in Regulating Lung Fluid Balance in Lipopolysaccharide-induced Acute Lung Injury and Infection-Related Acute Respiratory Distress Syndrome.
|
28 |
Rage KO
(1 time)
|
Endocrinology (1 time)
|
AT2 (1 time) KO (1 time)
|
2010 Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor.
|
29 |
RAGE-apt
(1 time)
|
Natural Science Disciplines (1 time)
|
AGE (1 time) ALDO (1 time) CML (1 time)
|
2018 RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice.
|
30 |
RAGE-aptamers
(1 time)
|
Endocrinology (1 time)
|
AGEs (1 time)
|
2017 RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.
|
31 |
RAGE-v
(1 time)
|
Biochemistry (1 time)
|
---
|
2016 Biophysical characterization of Ca2+-binding of S100A5 and Ca2+-induced interaction with RAGE.
|
32 |
raised against receptor for AGEs
(1 time)
|
Endocrinology (1 time)
|
ADMA (1 time) AGEs (1 time) DDAH (1 time)
|
2013 Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction.
|
33 |
Raman-Activated Gravity-Driven Encapsulation
(1 time)
|
|
RACS (1 time) RAGE-Seq (1 time)
|
2021 One-Cell Metabolic Phenotyping and Sequencing of Soil Microbiome by Raman-Activated Gravity-Driven Encapsulation (RAGE).
|
34 |
RANKL and receptor for AGE
(1 time)
|
Endocrinology (1 time)
|
OPG (1 time) RANK (1 time) RANKL (1 time)
|
2014 RANKL-OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy.
|
35 |
Rapid analysis of gene expression
(1 time)
|
Biochemistry (1 time)
|
---
|
1999 Rapid analysis of gene expression (RAGE) facilitates universal expression profiling.
|
36 |
recently, AGE-their receptor
(1 time)
|
Medicine (1 time)
|
AGE (1 time) AGEs (1 time)
|
2005 Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end product (AGE)-related disorders.
|
37 |
Recently, the activation of the advanced glycation endproducts receptor
(1 time)
|
Vascular Diseases (1 time)
|
NFAT (1 time) siRNA (1 time) STAT (1 time)
|
2011 RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes.
|
38 |
receptor expression for AGEs
(1 time)
|
Cardiology (1 time)
|
AGE-HSA (1 time) AGEs (1 time) EMSA (1 time)
|
2008 Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways.
|
39 |
receptor for advanced AGEs
(1 time)
|
|
ACS (1 time) AGEs (1 time) cTnI (1 time)
|
2012 Inverse Association between Cardiac Troponin-I and Soluble Receptor for Advanced Glycation End Products in Patients with Non-ST-Segment Elevation Myocardial Infarction.
|
40 |
receptor for advanced glycation end products advanced glycation end products
(1 time)
|
Neoplasms (1 time)
|
CRC (1 time) HMGB1 (1 time) NF-kappaB (1 time)
|
2018 Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
|
41 |
receptor for glycer-AGEs
(1 time)
|
Chemistry (1 time)
|
GLAP (1 time) ROS (1 time) RT-PCR (1 time)
|
2020 Glyceraldehyde-Derived Pyridinium Evokes Renal Tubular Cell Damage via RAGE Interaction.
|
42 |
receptor gene for advanced glycation
(1 time)
|
Gynecology (1 time)
|
---
|
2010 Implication of the RAGE-EN-RAGE axis in endometriosis.
|
43 |
receptor ligation
(1 time)
|
Nutritional Sciences (1 time)
|
AGEs (1 time) COX-2 (1 time) MAPK (1 time)
|
2006 Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for AGEs.
|
44 |
receptor of AGE expression
(1 time)
|
Nephrology (1 time)
|
AGEs (1 time) HPMC (1 time) PD (1 time)
|
2002 AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression.
|
45 |
Receptor pro konene produkty pokroile glykace
(1 time)
|
Internal Medicine (1 time)
|
AGEs (1 time)
|
2014 [Receptor pro konene produkty pokroile glykace (RAGE) - kliovy hra diabeticke angiopatie?].
|
46 |
receptor protein for AGE
(1 time)
|
Medicine (1 time)
|
AD (1 time) AGEs (1 time) sRAGE (1 time)
|
2012 Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease.
|
47 |
receptor was investigated for AGE
(1 time)
|
Ophthalmology (1 time)
|
AGEs (1 time) CEC (1 time)
|
2003 Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells.
|
48 |
receptors including those of the final glucosiding product
(1 time)
|
Physiology (1 time)
|
---
|
2006 [Participation of the DNA-binding cytokine amphoterine in triggering the processes of tissue reparation].
|
49 |
receptors of end-glycosylated products
(1 time)
|
Cell Membrane (1 time)
|
ACE2 (1 time) RAS (1 time)
|
2021 The Balance between Two Branches of RAS Can Protect from Severe COVID-19 Course.
|
50 |
receptors placed on neighboring cells
(1 time)
|
Biochemistry (1 time)
|
AGE (1 time)
|
2011 Transmission of prions within the gut and towards the central nervous system.
|
51 |
receptors, including advanced glycation end product-specific receptor
(1 time)
|
Nephrology (1 time)
|
AGEs (1 time)
|
2015 Uremic Toxicity of Advanced Glycation End Products in CKD.
|
52 |
recognized by AGE receptors
(1 time)
|
Chemistry, Clinical (1 time)
|
AGEs (1 time) NF-kB (1 time)
|
2006 Glycation endproducts in osteoporosis--is there a pathophysiologic importance?
|
53 |
recombination-dependent activatable gene expression
(1 time)
|
Biochemistry (1 time)
|
AR (1 time) beta-AR (1 time) EGFP (1 time)
|
2006 Inducible model for beta-six-mediated site-specific recombination in mammalian cells.
|
54 |
reduce the expression of AGEs-induced AGEs receptor
(1 time)
|
Molecular Biology (1 time)
|
AGEs (1 time) APOE (1 time) ATV (1 time)
|
2020 Effect of atorvastatin on AGEs-induced injury of cerebral cortex via inhibiting NADPH oxidase -NF-kappaB pathway in ApoE-/- mice.
|
55 |
reductase pathway and the increased AGE interactions with its receptor
(1 time)
|
Science (1 time)
|
AGEs (1 time)
|
2005 Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury.
|
56 |
regulated by the AGES-receptor
(1 time)
|
Cell Biology (1 time)
|
AGEs (1 time) VSMC (1 time)
|
2016 Glycolaldehyde-derived advanced glycation end products (glycol-AGEs)-induced vascular smooth muscle cell dysfunction is regulated by the AGES-receptor (RAGE) axis in endothelium.
|
57 |
regulated by the membrane receptors for Abeta1-42 peptides
(1 time)
|
Pharmacology (1 time)
|
---
|
2012 Anti-Abeta-MAb and dually decorated nanoliposomes: effect of Abeta1-42 peptides on interaction with hCMEC/D3 cells.
|
58 |
related to AGE-receptor for AGE
(1 time)
|
Nephrology (1 time)
|
AGE (1 time) GDP (1 time) PDF (1 time)
|
2005 Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.
|
59 |
relatively little AGE-receptor
(1 time)
|
Nephrology (1 time)
|
AGE-HSA (1 time)
|
1999 The use of optical sensors to understand cellular interactions with renal cells.
|
60 |
Removal of alleles by genome editing
(1 time)
|
Biology (1 time)
|
---
|
2019 Removal of alleles by genome editing (RAGE) against deleterious load.
|
61 |
removal of deleterious alleles by genome editing
(1 time)
|
Biology (1 time)
|
---
|
2019 Removal of alleles by genome editing (RAGE) against deleterious load.
|
62 |
renal AGEs-receptor
(1 time)
|
Biochemistry (1 time)
|
AGEs (1 time) CC (1 time) CML (1 time)
|
2021 Ezetimibe attenuates experimental diabetes and renal pathologies via targeting the advanced glycation, oxidative stress and AGE-RAGE signalling in rats.
|
63 |
renal hypertrophy as well as overexpression of AGE receptors
(1 time)
|
Endocrinology (1 time)
|
AGE (1 time) LZ (1 time) MS (1 time)
|
2008 Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy.
|
64 |
renaturing agarose gel electrophoresis
(1 time)
|
Toxicology (1 time)
|
AE (1 time) DDC (1 time) DPC (1 time)
|
1998 Differential sensitivity of chromium-mediated DNA interstrand crosslinks and DNA-protein crosslinks to disruption by alkali and EDTA.
|
65 |
Research Diagnostics, Flanders, NJ
(1 time)
|
Brain (1 time)
|
AD (1 time)
|
2008 Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease.
|
66 |
response is attributed to apically oriented AGE receptors
(1 time)
|
Ophthalmology (1 time)
|
AGE (1 time) DME (1 time) RPE (1 time)
|
2015 Receptor mediated disruption of retinal pigment epithelium function in acute glycated-albumin exposure.
|
67 |
responses, AGE receptors
(1 time)
|
Neurology (1 time)
|
LBs (1 time) MDAL (1 time) PD (1 time)
|
2010 Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment.
|
68 |
Rhythmic Analysis of Gene Expression
(1 time)
|
Medical Informatics (1 time)
|
---
|
2003 Phase-independent rhythmic analysis of genome-wide expression patterns.
|
69 |
robust increase in both myocardial AGE receptor
(1 time)
|
Cell Biology (1 time)
|
AGEs (1 time) CD (1 time)
|
2018 Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose.
|
70 |
role of advanced glycation end products(AGEs) and their receptor
(1 time)
|
Ophthalmology (1 time)
|
AGEs (1 time)
|
2005 [Molecular mechanism of diabetic retinopathy: role of advanced glycation end products(AGEs) and their receptor (RAGE) in the pathogenesis of diabetic retinopathy].
|
71 |
role of AGEs and of their specific receptors
(1 time)
|
Endocrinology (1 time)
|
AGEs (1 time)
|
2001 Advanced glycation end products, their receptors and diabetic angiopathy.
|
72 |
roles of high-mobility group box-1, advanced glycation end-products receptors
(1 time)
|
Pharmacology (1 time)
|
---
|
2009 Inflammation in ischaemic brain injury: current advances and future perspectives.
|
73 |
rotavirus acute gastroenteritis
(1 time)
|
Allergy and Immunology (1 time)
|
RV (1 time)
|
2013 A reverse evidence of rotavirus vaccines impact.
|
74 |
ruling out effects of cellular advanced glycation end product receptor
(1 time)
|
Dermatology (1 time)
|
---
|
2002 Photosensitized growth inhibition of cultured human skin cells: mechanism and suppression of oxidative stress from solar irradiation of glycated proteins.
|
75 |
superfamily--receptor for advanced glycation endproducts
(1 time)
|
Therapeutics (1 time)
|
FH1 (1 time)
|
2015 The multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic disease.
|
76 |
up-regulation of receptor for AGEs
(1 time)
|
Pharmacology (1 time)
|
AGEs (1 time) GS (1 time) IL-6 (1 time)
|
2014 Polyphenol isolated from Corni Fructus, 7-O-galloyl-D-sedoheptulose, modulates advanced glycation endproduct-related pathway in type 2 diabetic db/db mice.
|
77 |
up-regulation of the advanced glycation end product receptors
(1 time)
|
Cell Biology (1 time)
|
HMGB1 (1 time)
|
2011 Hyperlipidemia stimulates the extracellular release of the nuclear high mobility group box 1 protein.
|